COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking

Title
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
Authors
Keywords
SARS-CoV-2, COVID-19, Therapies, Drugs, SARS-CoV-1, Coronavirus, Treatment, Tocilizumab, Remdesivir, Emapalumab, Eculizumab, Ruxolitinib, Baricitinib, Dexamethasone, Coagulation, Inflammation
Journal
VIRUS RESEARCH
Volume 286, Issue -, Pages 198070
Publisher
Elsevier BV
Online
2020-06-20
DOI
10.1016/j.virusres.2020.198070

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now